Stuart Jebb

Chief Revenue Officer at Glutagen

Speaker

Stuart Jebb is the Chief Revenue Officer at Glutagen, where he leads the company's expansion strategy with a focus on out-licensing, joint ventures, and strategic partnerships in respect of Glutagen's flagship OTC gluten symptom prevention product, GluteGuard.

Awarded the 2023 Outstanding & Innovative New Consumer Healthcare Product by Consumer Healthcare Products Australia for its "life changing" impact on those with gluten related disorders, GluteGuard is the only product in the world clinically proven to protect against the symptoms of accidental gluten ingestion in celiac disease and other gluten related disorders.

With GluteGuard out-licensing transactions already signed in respect of Canada and the Middle East, Stuart is focused on expanding the GluteGuard brand into remaining key markets, including the United States, United Kingdom, Europe, New Zealand, and Latin America.

Prior to joining Glutagen, Stuart worked as an M&A and Capital Markets lawyer advising a broad range of clients including multinational manufactures, publicly listed entities and private investment groups.